Swiss Life Asset Management Ltd grew its holdings in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 48.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 8,978 shares of the company’s stock after buying an additional 2,926 shares during the quarter. Swiss Life Asset Management Ltd’s holdings in Astera Labs were worth $1,494,000 as of its most recent filing with the SEC.
A number of other hedge funds also recently made changes to their positions in ALAB. Nordea Investment Management AB bought a new position in shares of Astera Labs in the fourth quarter valued at approximately $2,028,000. Geneva Partners LLC bought a new position in shares of Astera Labs in the third quarter valued at approximately $1,876,000. Numerai GP LLC raised its stake in shares of Astera Labs by 153.1% in the third quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after acquiring an additional 7,992 shares during the last quarter. Handelsbanken Fonder AB raised its stake in shares of Astera Labs by 289.5% in the third quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock valued at $24,710,000 after acquiring an additional 93,800 shares during the last quarter. Finally, Paragon Advisors LLC bought a new position in shares of Astera Labs in the third quarter valued at approximately $1,829,000. Institutional investors and hedge funds own 60.47% of the company’s stock.
Astera Labs Stock Up 1.8%
Shares of ALAB opened at $232.68 on Friday. Astera Labs, Inc. has a 12-month low of $84.78 and a 12-month high of $262.90. The firm has a market capitalization of $39.88 billion, a PE ratio of 157.22, a price-to-earnings-growth ratio of 3.03 and a beta of 3.35. The stock’s fifty day simple moving average is $155.40 and its 200-day simple moving average is $156.41.
Insider Buying and Selling
In related news, CEO Jitendra Mohan sold 139,951 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the completion of the sale, the chief executive officer directly owned 3,929,183 shares of the company’s stock, valued at $786,465,269.28. The trade was a 3.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $200.03, for a total transaction of $701,105.15. Following the sale, the director directly owned 63,639 shares of the company’s stock, valued at approximately $12,729,709.17. This trade represents a 5.22% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,497,338 shares of company stock valued at $236,827,957 over the last ninety days. Insiders own 12.50% of the company’s stock.
Trending Headlines about Astera Labs
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Northland Securities sharply raised its earnings outlook for Astera Labs (ALAB) across multiple periods, including FY2026, FY2027, and several quarterly estimates, signaling stronger expected profitability ahead.
- Positive Sentiment: Analyst sentiment is also improving elsewhere, with another report lifting ALAB’s price target to $246.06, reinforcing the view that Wall Street sees more upside in the stock. Astera Labs price target increased by 20.85% to 246.06
- Positive Sentiment: Zacks highlighted strong UALink 2.0 momentum and Scorpio switch expansion, saying these products are helping drive Astera Labs’ AI infrastructure growth and could support additional upside as deployments build into 2027. ALAB Benefits From Strong UALink Growth: More Upside Ahead?
Analyst Upgrades and Downgrades
A number of analysts have recently weighed in on the company. Barclays raised their target price on Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. JPMorgan Chase & Co. raised their target price on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Morgan Stanley raised their target price on Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Roth Mkm restated a “buy” rating and issued a $275.00 target price on shares of Astera Labs in a research note on Wednesday, May 6th. Finally, TD Cowen increased their price target on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Fifteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $229.65.
Check Out Our Latest Analysis on ALAB
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
- Five stocks we like better than Astera Labs
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
